Chakrabarti M K, Bhattacharya J, Bhattacharya M K, Nair G B, Bhattacharya S K, Mahalanabis D
Society for Applied Studies and National Institute of Cholera, Calcutta, India.
Acta Paediatr. 1999 Feb;88(2):161-5. doi: 10.1080/08035259950170321.
The protective efficacy of an orally administered heat-killed virulent strain of Shigella flexneri 2a (5 weekly oral doses) was evaluated in 25 rabbits (14 immunized and 11 non-immunized controls) against challenge with the same strain of Shigella using the rabbit model of shigellosis. All 11 non-immunized rabbits developed bloody diarrhoea following challenge and 6 (54%) died. None of the 14 immunized rabbits developed diarrhoea (all had pellet stools) but 3 (21%) died from causes not associated with diarrhoea. Protection from diarrhoea and dysentery following oral immunization with a killed Shigella species was 100% and highly significant. Death following challenge was 2.5-fold higher in the non-immunized group (p = 0.115) but was not significant. These promising results suggest that further studies should be undertaken to develop a killed oral vaccine against shigellosis.
在25只兔子(14只免疫和11只非免疫对照)中,使用志贺氏菌病兔模型,评估口服热灭活的福氏志贺氏菌2a强毒株(每周口服5剂)对相同菌株攻击的保护效力。所有11只非免疫兔子在攻击后出现血性腹泻,6只(54%)死亡。14只免疫兔子均未出现腹泻(粪便均为颗粒状),但3只(21%)死于与腹泻无关的原因。口服灭活志贺氏菌属进行免疫后,预防腹泻和痢疾的保护率为100%,且具有高度显著性。攻击后非免疫组的死亡率高出2.5倍(p = 0.115),但无显著性差异。这些有前景的结果表明,应进一步开展研究以开发一种针对志贺氏菌病的灭活口服疫苗。